Fenbendazole

Fenbendazole is a veterinary antiparasitic medication that has gained attention for potential anti-cancer properties following anecdotal reports and laboratory studies. Research suggests it may disrupt cancer cell microtubules, inhibit glucose uptake, and induce cell death, though human clinical evidence remains preliminary.

Why Fenbendazole Is Being Studied for Cancer

  • May disrupt microtubule function similar to some chemotherapy drugs

  • Shows potential to inhibit cancer cell glucose uptake

  • Demonstrates ability to induce apoptosis in laboratory studies

  • May reactivate p53 tumor suppressor gene

  • Low toxicity profile observed in animal studiesCancer Types Being Studied

Cancer Types Being Studied

  • Lung cancer

  • Colorectal cancer

  • Prostate cancer

  • Lymphoma

  • Melanoma

  • Pancreatic cancer

Related Topics in Our Archive

  • Fenbendazole cancer protocol

  • Fenbendazole and mebendazole

  • Fenbendazole p53

  • Fenbendazole dosage

  • Benzimidazole cancer

Common Research Questions

  • What is the dosage used in cancer protocols?

  • How does fenbendazole compare to mebendazole?

  • Is fenbendazole safe for human use?

  • What clinical evidence exists for cancer treatment?

What Researchers Are Studying

  • Mechanisms of microtubule disruption

  • Comparison with approved benzimidazole drugs

  • Safety profile in humans

  • Potential clinical trial development

Browse Fenbendazole Research

→ Search our archive for "fenbendazole"

Disclaimer

This page is for informational purposes only. Always consult your oncologist before adding any supplement to your treatment plan.